PLpro inhibitor
PLpro inhibitor Basic information
- Product Name:
- PLpro inhibitor
- Synonyms:
-
- PLpro inhibitor
- 5-(Acetylamino)-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]benzamide
- 5-Acetylamino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide
- 5-(acetylamino)-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]-
- BENZAMIDE; 5-(ACETYLAMINO)-2-METHYL-N-[(1R)-1-(1-NAPHTHALENYL)ETHYL]-
- 5-acetamido-2-methyl-N-[2-(1-naphthalenyl)ethyl]benzamide
- 5-acetylamino-2-methyl-N-[(R)-1-(1-naphthyl)ethyl]benzamide
- 5-acetamido-2-methyl-n-(2-naphthalen-1-ylethyl)benzamide
- CAS:
- 1093070-14-4
- MF:
- C22H22N2O2
- MW:
- 346.42
- Mol File:
- 1093070-14-4.mol
PLpro inhibitor Chemical Properties
- Boiling point:
- 584.7±50.0 °C(Predicted)
- Density
- 1.189±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- DMF: 30 mg/ml; DMSO: 30 mg/ml
- form
- Powder
- pka
- 14.13±0.46(Predicted)
- color
- White to off-white
PLpro inhibitor Usage And Synthesis
Uses
PLpro inhibitor is a potent inhibitor of papain-like protease (PLpro) with an IC50 of 2.6 μM[1]. PLpro inhibitor inhibits SARS-CoV-2 PLpro with an IC50 of 5.0 μM and an EC50 of 21.0 μM[2].
Definition
ChEBI: KOM70144 is a benzamide that is GRL-0617 in which one of the hydrogen's of the primary amino group is replaced by an acetyl group. It an inhibitor of SARS-CoV and SARS-CoV-2 papain-like protease (PLpro) with an IC50 of 2.6 muM and 5.0 muM, respectively. It also inhibits SARS-CoV and SARS-CoV-2 infection of Vero E6 cells in vitro (EC50 values are 13.1 and 21 muM, respectively). It has a role as a protease inhibitor and an anticoronaviral agent. It is a member of naphthalenes, a member of benzamides, a secondary carboxamide and a member of acetamides. It is functionally related to a GRL-0617.
storage
Store at -20°C
References
[1] Ratia, K., et al., A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A, 2008. 105(42): p. 16119-24. DOI:10.1073/pnas.0805240105
[2] http://www.google.com/patents/WO2010022355A1cl=en
[3] Brendan T Freitas, et al. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease. ACS Infect Dis. 2020 May 19. DOI:10.1021/acsinfecdis.0c00168
PLpro inhibitorSupplier
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- +86-21-5821 5861
- sales@letopharm.com
- Tel
- eric_feng1954@126.com
- Tel
- 16314854226
- info@bocsci.com